Test ID: MTHFR
5,10-Methylenetetrahydrofolate Reductase C677T, Mutation, Blood
NY State Approved 
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Useful For Suggests clinical disorders or settings where the test may be helpful
Direct mutation analysis for the MTHFR C677T mutation should be reserved for patients with coronary artery disease, acute myocardial infarction, peripheral vascular artery disease, stroke, or venous thromboembolism who have increased basal homocysteine levels or an abnormal methionine-load test.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Direct Mutation Analysis
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
MTHFR C677T Mutation Analysis, B
Aliases Lists additional common names for a test, as an aid in searching
5,10 Methylenetetrahydrofolate Reductase, C677T point mutation
A223V Gene Mutation, Methylenetetrahydrofolate reductase
C677T Point Mutation
Methylenetetrahydrofolate Reductase 5,10
MTHFR A223V Gene Mutation
MTHFR Deficiency thermolabile type
reductase C677T point mutation
A223V Gene Mutation, MTHFR Deficiency
A223V Gene Mutation, Methylenetetrahydrofolate reductase
C677T Point Mutation
Methylenetetrahydrofolate Reductase 5,10
MTHFR A223V Gene Mutation
MTHFR Deficiency thermolabile type
reductase C677T point mutation
A223V Gene Mutation, MTHFR Deficiency
External
link
PDF
document
Excel
document
Word
document